Focus Taiwan

• Major Taiwan dailies on Thursday reported a shift in investment trends, with foreign investors reportedly favoring Taiwanese stocks over South Korean ones. • President Lai emphasized the necessity for the DPP to win the Kaohsiung election despite interference from China, while Taiwan condemned a "dangerous" military drill. • Economic reports highlight that listed companies saw profits double in H1, supporting the Taiex rebound, as cooling inflation reduces pressure on U.S. interest rate hikes.

• TS Financial has launched a new sports program, featuring a spotlight on B-Girl Hsu Fu-ya and her debut performance at the Asian Games. • Botanicure presented clinical findings regarding the development of a botanical drug designed to treat early-stage dementia at the BIO International Convention. • These reports highlight significant advancements in Taiwan's sports representation and pharmaceutical research on a global stage.

• TS Financial has launched a new sports program, featuring the debut of B-Girl Hsu Fu-ya at the Asian Games. • Botanicure presented clinical findings regarding the development of a botanical drug designed to treat early dementia at the BIO International Convention. • These stories highlight Taiwan's current focus on athletic achievement and advancements in pharmaceutical research for neurodegenerative diseases.

• TSMC has raised its full-year outlook for the second time, with Chairman C.C. Wei predicting that AI demand will remain strong through 2030. • Political tension is rising as the Presidential Office, local governments, and various political parties exchange accusations regarding responsibility for a tainted oil scandal. • You Ying-lung has warned that the complexity of four specific referendum questions could delay vote counting until 3 a.m.

• Botanicure presented clinical findings for a botanical drug targeting early dementia during the BIO International Convention. • The presentation focused on the development and efficacy of botanical-based treatments to address cognitive decline in early-stage dementia patients. • This development is significant as it explores alternative, plant-derived pharmacological pathways to treat neurodegenerative diseases.

• Botanicure presented clinical findings regarding a botanical drug designed to treat early-stage dementia. • The presentation took place during the BIO International Convention, showcasing the company's latest research and development progress. • This development is significant as it explores botanical alternatives for managing cognitive decline in dementia patients.

• Botanicure presented clinical findings regarding its botanical drug development for early dementia at the BIO International Convention. • The presentation focused on the efficacy and safety of the botanical-based treatment in addressing cognitive decline. • This development is significant as it explores alternative, plant-derived therapeutic pathways for treating dementia, a growing global health challenge.

• Botanicure presented clinical findings regarding the development of a botanical drug for early dementia at the BIO International Convention. • The presentation highlighted the efficacy and safety data of their botanical drug candidate during the global biotechnology gathering. • This development is significant as it explores plant-based therapeutic alternatives for treating cognitive decline and early-stage dementia.

• Botanicure presented clinical findings regarding the development of a botanical drug for early dementia at the BIO International Convention. • The presentation highlighted the efficacy and progress of their botanical-based therapeutic approach to treating cognitive decline. • This development is significant as it explores alternative, plant-derived pharmacological pathways to address the growing global challenge of dementia.

• Botanicure presented clinical findings regarding the development of a botanical drug for early dementia at the BIO International Convention. • The presentation highlighted the efficacy and safety data of their botanical drug candidate during the global biotechnology gathering. • This development is significant as it explores plant-based therapeutic alternatives for treating cognitive decline and early-stage dementia.

• Botanicure presented clinical findings for a botanical drug designed to treat early dementia during the BIO International Convention. • The presentation highlighted the development process and efficacy of the botanical-based treatment for cognitive impairment. • This development is significant as it explores alternative, plant-derived pharmaceutical pathways to address the growing global burden of dementia.

• Botanicure presented clinical findings for a botanical drug targeting early dementia at the BIO International Convention. • The presentation focused on the development and efficacy of botanical-based treatments to address cognitive decline. • This research is significant as it explores alternative pharmaceutical pathways to treat dementia, a growing global health challenge.

• The 2026 Golden Melody Awards (GMA) will take place this Saturday at 7 p.m. at the Taipei Arena to honor achievements in the local pop music industry. • The event features a red carpet prelude and interviews with numerous celebrities and performing artists prior to the main awards ceremony. • The ceremony will be broadcast in Taiwan via Taiwan Television Enterprise (TTV) and streamed online through Line Today and Line Music.

• Botanicure presented clinical findings regarding the development of a botanical drug designed to treat early-stage dementia. • The findings were unveiled during the BIO International Convention, highlighting the company's progress in botanical pharmaceutical research. • This development is significant as it explores alternative, plant-based therapeutic pathways to address the growing global challenge of cognitive decline.

• US President Donald Trump arrived in Beijing on May 13, 2026, for a state visit and high-level talks with Chinese President Xi Jinping addressing major bilateral and global issues. • Key agenda items include US-China trade disputes, rare earth minerals supply chains, Taiwan's political status, artificial intelligence competition, and the ongoing Iran conflict. • The summit represents a critical diplomatic engagement aimed at managing US-China strategic competition and reducing military escalation risks.